Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 339.70
+2.20 (0.65%)
Apr 3, 2026, 1:44 PM IDT
Matricelf Market Cap
Matricelf has a market cap or net worth of 99.34 million as of April 2, 2026. Its market cap has increased by 81.15% in one year.
Market Cap
99.34M
Enterprise Value
79.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
339.70
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 99.34M, an increase of 60.24%. That is a compound annual growth rate of 10.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 99.34M | -34.62% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | 62.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 464.92M |
| Geffen Residence & Renewal | 271.49M |
| Clal Biotechnology Industries | 50.03M |
| BioLineRx | 31.33M |
| Evogene | 25.42M |
| Can-Fite BioPharma | 21.79M |
| BioLight Life Sciences | 21.20M |
| XTL Biopharmaceuticals | 18.92M |